Nuvation Bio Hits Day High with Strong 8.72% Intraday Surge

Nuvation Bio, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable uptick in its stock price, gaining 8.72% on March 4, 2026. The stock reached an intraday high of USD 4.79, marking a significant moment in its trading activity for the day. Despite this positive movement, Nuvation Bio's performance over the past week has seen a decline of 14.75%, and a more substantial drop of 19.11% over the past month. However, the company has shown remarkable resilience over the past year, with a staggering return of 160.44%, significantly outperforming the S&P 500, which recorded a gain of 17.36% during the same period. Financial metrics indicate that Nuvation Bio is navigating a challenging landscape, with negative operating cash flow reported at USD -168.19 million and a return on equity of -66.48%. The company’s market capitalization stands at USD 1.87 billion, reflecting its position within the small-cap segment. As the stock continues to navigate its current market dynamics, its recent high may serve as a focal point for ongoing investor observation.